UCLA researchers found NDRG1 builds up in old muscle stem cells, slowing repair but boosting survival. Blocking it speeds ...
FDA’s rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed modules ...
A new review was published in Volume 18 of Aging on May 30, 2026, titled "The love and hate relationship between cellular ...
Individual differences in toddler temperament—including activity, emotionality, sociability, and shyness—are influenced in ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...
FDA's rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed modules of the NDA before the full application is submitted FDA previously granted ...
Palvella Therapeutics Inc (NASDAQ:PVLA) shares gained 5% in premarket trading on Monday after the company announced that the U. S.
A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...
The high-grade glioma market is witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing awareness, and advancements ...
FDA’s rolling review process is intended to facilitate expedited review, enabling FDA to begin evaluating completed sections ...
Dose-optimization data from the Phase 1 study expected Q3 2026 to support Phase 2 proof-of-concept initiation in ADPKD in Q4 2026JERSEY CITY, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc.
For decades, fitness culture drew a hard line in the sand. You were either a strength athlete or an endurance athlete. Cardio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results